223 related articles for article (PubMed ID: 26410440)
1. Comparison of intermittent versus continuous vancomycin infusion for the treatment of late-onset sepsis in preterm infants.
Demirel B; İmamoglu E; Gursoy T; Demirel U; Topçuoglu S; Karatekin G; Ovali F
J Neonatal Perinatal Med; 2015; 8(2):149-55. PubMed ID: 26410440
[TBL] [Abstract][Full Text] [Related]
2. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
Plan O; Cambonie G; Barbotte E; Meyer P; Devine C; Milesi C; Pidoux O; Badr M; Picaud JC
Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F418-21. PubMed ID: 18450803
[TBL] [Abstract][Full Text] [Related]
3. Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.
Hill LF; Clements MN; Turner MA; Donà D; Lutsar I; Jacqz-Aigrain E; Heath PT; Roilides E; Rawcliffe L; Alonso-Diaz C; Baraldi E; Dotta A; Ilmoja ML; Mahaveer A; Metsvaht T; Mitsiakos G; Papaevangelou V; Sarafidis K; Walker AS; Sharland M;
Lancet Child Adolesc Health; 2022 Jan; 6(1):49-59. PubMed ID: 34843669
[TBL] [Abstract][Full Text] [Related]
4. Continuous vs. intermittent vancomycin therapy for Gram-positive infections not caused by methicillin-resistant Staphylococcus aureus.
Duszynska W; Taccone FS; Hurkacz M; Wiela-Hojenska A; Kübler A
Minerva Anestesiol; 2016 Mar; 82(3):284-93. PubMed ID: 26184702
[TBL] [Abstract][Full Text] [Related]
5. Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
van Maarseveen EM; Gipmans S; Vasbinder E; Petjak M; van Zanten AR
Ther Drug Monit; 2016 Jun; 38(3):398-401. PubMed ID: 26926670
[TBL] [Abstract][Full Text] [Related]
6. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.
Akers KS; Cota JM; Chung KK; Renz EM; Mende K; Murray CK
J Burn Care Res; 2012; 33(6):e254-62. PubMed ID: 22878490
[TBL] [Abstract][Full Text] [Related]
7. Neonatal vancomycin continuous infusion: still a confusion?
Gwee A; Cranswick N; Metz D; Coghlan B; Daley AJ; Bryant PA; Curtis N
Pediatr Infect Dis J; 2014 Jun; 33(6):600-5. PubMed ID: 24378952
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin for prophylaxis against sepsis in preterm neonates.
Craft AP; Finer NN; Barrington KJ
Cochrane Database Syst Rev; 2000; 2000(2):CD001971. PubMed ID: 10796456
[TBL] [Abstract][Full Text] [Related]
9. A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.
Beumier M; Roberts JA; Kabtouri H; Hites M; Cotton F; Wolff F; Lipman J; Jacobs F; Vincent JL; Taccone FS
J Antimicrob Chemother; 2013 Dec; 68(12):2859-65. PubMed ID: 23800905
[TBL] [Abstract][Full Text] [Related]
10. Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy.
Covajes C; Scolletta S; Penaccini L; Ocampos-Martinez E; Abdelhadii A; Beumier M; Jacobs F; de Backer D; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2013 Mar; 41(3):261-6. PubMed ID: 23312601
[TBL] [Abstract][Full Text] [Related]
11. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
Waineo MF; Kuhn TC; Brown DL
J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
[TBL] [Abstract][Full Text] [Related]
13. Continuous intravenous administration of vancomycin in medical intensive care unit patients.
Saugel B; Nowack MC; Hapfelmeier A; Umgelter A; Schultheiss C; Thies P; Phillip V; Eyer F; Schmid RM; Huber W
J Crit Care; 2013 Feb; 28(1):9-13. PubMed ID: 22459156
[TBL] [Abstract][Full Text] [Related]
14. [Continuous and intermittent infusion of vancomycin equally effective: review of the literature].
van Maarseveen EM; Man WH; Touw DJ; Bouma AW; van Zanten AR
Ned Tijdschr Geneeskd; 2011; 155(42):A2667. PubMed ID: 22027450
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of intravenous colistin in preterm infants with nosocomial sepsis caused by Acinetobacter baumannii.
Alan S; Yildiz D; Erdeve O; Cakir U; Kahvecioglu D; Okulu E; Ates C; Atasay B; Arsan S
Am J Perinatol; 2014 Dec; 31(12):1079-86. PubMed ID: 24584997
[TBL] [Abstract][Full Text] [Related]
16. Continuous insulin infusion in hyperglycaemic extremely-low- birth-weight neonates.
Ng SM; May JE; Emmerson AJ
Biol Neonate; 2005; 87(4):269-72. PubMed ID: 15695923
[TBL] [Abstract][Full Text] [Related]
17. Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application.
Tafelski S; Nachtigall I; Troeger U; Deja M; Krannich A; Günzel K; Spies C;
J Infect Public Health; 2015; 8(4):355-63. PubMed ID: 25794497
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Pharmacotherapy; 1998; 18(5):1069-74. PubMed ID: 9758317
[TBL] [Abstract][Full Text] [Related]
19. How to use vancomycin optimally in neonates: remaining questions.
Jacqz-Aigrain E; Leroux S; Zhao W; van den Anker JN; Sharland M
Expert Rev Clin Pharmacol; 2015; 8(5):635-48. PubMed ID: 26289222
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin pharmacokinetics and dosing in premature neonates.
McDougal A; Ling EW; Levine M
Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
